KRIYA OPHTHALMOLOGY
Live / Registered — Registered (as of 07 Jul 2026)
What this means for you
Registered since 07 Jul 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Jul 2032: the §8 declaration of use).
Record
- Serial number
- 97077241
- Registration number
- 8335684
- Mark type
- Word mark
- Filed
- 15 Oct 2021
- Published for opposition
- 14 Mar 2023
- Registered
- 07 Jul 2026
- Next maintenance filing
- §8 declaration of use, due by 07 Jul 2032 (grace period to 07 Jan 2033)
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for gene therapy; pharmaceutical preparations for the treatment of chronic diseases, cancer, or infectious diseases, namely, ophthalmic-related diseases and disorders of the eye; biochemical preparations for use in medical industry, namely, biochemical preparations for the treatment of ophthalmic-related diseases
Owner
- Kriya Therapeutics, Inc., Morrisville, NC, US
- Kriya Therapeutics, Inc., Morrisville, NC, US
- Kriya Therapeutics, Inc., Palo Alto, CA, US
Prosecution history
- 07 Jul 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Jul 2026 — REGISTERED-PRINCIPAL REGISTER
- 15 Jun 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Jun 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 21 May 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 11 May 2026 — USE AMENDMENT FILED
- 11 May 2026 — TEAS STATEMENT OF USE RECEIVED
- 20 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Jan 2026 — SOU EXTENSION 5 GRANTED
- 05 Nov 2025 — SOU EXTENSION 5 FILED
- 06 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 01 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 May 2025 — SOU EXTENSION 4 GRANTED
- 30 Apr 2025 — SOU EXTENSION 4 FILED
- 30 Apr 2025 — SOU TEAS EXTENSION RECEIVED